AllianceBernstein
PRTK

AllianceBernstein’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

AllianceBernstein’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-63,800
Closed -$189K – 3430
2022
Q1 		$189K Buy
63,800
+200
+0.3% +$752 ﹤0.01% 3004
2021
Q4 		$286K Hold
63,600
– – ﹤0.01% 2958
2021
Q3 		$309K Hold
63,600
– – ﹤0.01% 2943
2021
Q2 		$434K Buy
63,600
+9,800
+18% +$79.2K ﹤0.01% 2872
2021
Q1 		$380K Sell
53,800
-4,400
-8% -$31.7K ﹤0.01% 2802
2020
Q4 		$364K Sell
58,200
-3,800
-6% -$22.4K ﹤0.01% 2754
2020
Q3 		$335K Hold
62,000
– – ﹤0.01% 2758
2020
Q2 		$324K Buy
62,000
+5,600
+10% +$24.9K ﹤0.01% 2844
2020
Q1 		$178K Buy
56,400
+10,100
+22% +$37.3K ﹤0.01% 2829
2019
Q4 		$187K Hold
46,300
– – ﹤0.01% 2937
2019
Q3 		$200K Hold
46,300
– – ﹤0.01% 2947
2019
Q2 		$185K Buy
46,300
+2,100
+5% +$9.99K ﹤0.01% 2988
2019
Q1 		$237K Sell
44,200
-2,000
-4% -$12.9K ﹤0.01% 2853
2018
Q4 		$237K Buy
46,200
+2,000
+5% +$15.2K ﹤0.01% 2827
2018
Q3 		$429K Hold
44,200
– – ﹤0.01% 2685
2018
Q2 		$451K Buy
44,200
+10,400
+31% +$118K ﹤0.01% 2654
2018
Q1 		$439K Buy
33,800
+7,200
+27% +$107K ﹤0.01% 2552
2017
Q4 		$476K Hold
26,600
– – ﹤0.01% 2550
2017
Q3 		$668K Buy
26,600
+5,700
+27% +$133K ﹤0.01% 2471
2017
Q2 		$504K Buy
20,900
+8,700
+71% +$192K ﹤0.01% 2613
2017
Q1 		$235K Hold
12,200
– – ﹤0.01% 2802
2016
Q4 		$188K Buy
12,200
+1,300
+12% +$16.9K ﹤0.01% 2906
2016
Q3 		$142K Buy
+10,900
New +$145K ﹤0.01% 2902
2013
Q3 		– Sell
-49
Closed -$2K – 3512
2013
Q2 		$2K Buy
+49
New +$2.1K ﹤0.01% 3220

Other funds holding PRTK

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

AllianceBernstein's PRTK Position: Q2 2022 in Review

AllianceBernstein sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2022, closing a stake of 63,800 shares — an estimated $189K sold.

AllianceBernstein first reported a position in PRTK in Q2 2013 and held it in 24 quarters. The position peaked at $668K in Q3 2017. 84 funds tracked by Wall St. Rank hold PRTK as of Q2 2022.

  • AllianceBernstein reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • AllianceBernstein sold 63,800 Paratek Pharmaceuticals, Inc. shares in Q2 2022, an estimated $189K.
  • AllianceBernstein first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 24 quarters.
  • AllianceBernstein's Paratek Pharmaceuticals, Inc. position peaked at $668K in Q3 2017.
  • 84 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.